Western medicine in India is an expensive and cumbersome business, especially when compared to the cost of the drugs it provides.
A Fever, which is a sudden attack of fevers, can be very devastating for a family and a country.
It is often treatable with antibiotics and, for those who have never been treated with antibiotics, a cold and fever vaccine.
A new report, published in The Lancet Infectious Diseases, provides a snapshot of the healthcare landscape in India and outlines the challenges and opportunities that are facing it.
The report, titled ‘Western medicine and India’, describes how the pharmaceutical industry is increasingly becoming a competitor for the health care system in India.
This competition has become increasingly difficult to overcome, as more and more countries are investing heavily in western medicine.
In addition, western medicine is more widely available and more affordable than Indian medicine.
The report points out that the costs of western medicine have increased in comparison to the health outcomes that western medicine provides, particularly in the developing world.
The cost of western medicines has risen to over $1.5 trillion in the US alone, while India is projected to spend about $4.3 trillion on western medicine in the next five years.
The western medicine industry, which provides drugs and treatment to around 15 million people in India, is also becoming more competitive with traditional medicine, which includes traditional Chinese medicines and traditional Indian medicines.
While western medicine has become a lucrative business in India in the past, there are challenges in this industry, including a lack of regulatory oversight and the difficulty in identifying who is providing western medicine and who is not.
Dr. Ravi K. Yadav, a senior consultant at the Indian Society for Microbiology, has been working with western medicine since 2009.
He said that many patients don’t have access to western medicine due to their inability to afford it, including rural areas.
“In the developed world, western medical is available to everyone.
But for poor people in rural areas, who have limited access to healthcare, western is difficult to obtain,” Dr. Yadov told The Hindu.
“The lack of information and transparency in the Indian medical system means that it is not always easy to know the difference between western medicine available in rural and urban areas.
This is why we need to bring more transparency to the western medical sector in India,” he said.
In 2016, the Indian government signed a Memorandum of Understanding with the World Health Organization (WHO) on the creation of a national regulatory body for the industry.
The agreement states that all western medicine products that are made in India must be manufactured by Indian manufacturers and have an independent and transparent regulatory body.
Under the new agreement, Indian manufacturers will be responsible for ensuring that the medicines are manufactured in India within a reasonable time frame.
This will also require the government to set up a regulatory authority in India to oversee western medicine imports.
India will also have to set a national standard for the quality of medicines that are manufactured.
Dr. K.V. Sharma, chairman of the National Indian Pharmaceutical Manufacturers’ Association, said that the Indian pharmaceutical industry needs to get involved with international standards, especially in the area of drug safety and quality.
“In India, we need a strong regulatory authority and a regulatory agency for western medicine which is not only required but also mandated by the WHO,” he told The Huffington Post India.